Subpotent Oral Solution Prompts Recall of Hypothyroidism Treatment
The use of recalled products may lead to signs and symptoms of hypothyroidism.
Home
Short Sleep Duration Is Risk Factor for Poorly Controlled Asthma
How does sleep duration affect asthma control and exacerbations, and what clinical characteristics are found in patients who have with varying levels of sleep duration?
Medical Practices Face Widespread Staff Shortages
Physician retirements and challenges in recruiting and retaining staff are among the reasons medical practices are struggling with staff shortages.
Beta-Blocker Use Tied to Reductions in Violence
Seena Fazel of the University of Oxford, UK, and colleagues at the Karolinska Institute in Sweden compared the medicated and non-medicated periods of over 1.4 million beta blocker users.
Jesduvroq Approved for Anemia of CKD in Patients on Dialysis
Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor
A new dosing regimen for Turalio® (pexidartinib) is now available for the treatment of adults with symptomatic tenosynovial giant cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery. The recommended dose of Turalio is now 250mg orally twice daily (taken as two 125mg capsules) with a low-fat meal…
Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued
The pembrolizumab combination was not associated with an improvement in overall survival or radiographic progression-free survival.
What Is the Role of Palliative Care in Outpatient Oncology?
Palliative care should be viewed as a supportive element of care for patients with chronic illnesses at all stages of their disease.
Briumvi Now Available for Multiple Sclerosis Treatment
The CD20-directed cytolytic antibody therapy was approved based on data from two phase 3 trials.
Novel Oral Anticoagulant Fast Tracked for Patients With ESRD and Atrial Fibrillation
Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...